Glycogen storage disease type V
Glycogen storage disease type V, also known as McArdle disease, is a metabolic disorder characterized by a deficiency of the enzyme myophosphorylase, which impairs the body's ability to break down glycogen in muscles, leading to symptoms such as fatigue, cramps, and muscle pain. This rare condition occurs in about one in 100,000 individuals.
Health Outcomes
- Enhanced Glycogen Storage
- Enhanced Strength
- Healthy Age-Appropriate Growth
- Improved Carbohydrate Oxidation
- Improved Chest Press Strength
- Improved Glycogen Synthetase Activity
- Improved Growth and Economic Traits
- Improved Isometric Maximal Voluntary Contraction Torque
- Improved Maximal Voluntary Contraction
- Improved Muscle Recovery
- Improved Peak Anaerobic Power
- Improved Repeated Sprint Ability
- Improved Skeletal Muscle Damage
- Improved Skeletal Muscle Function
- Improved Strength Endurance
- Improved Strength and Power Performance
- Improved Total Load Lifted
- Increased Blood Lactate Level
- Increased Fat Oxidation
- Increased Hepatic Glycogen Storage
- Maintained Metabolic Homeostasis
- No Improvement in Growth Performance
- Reduced Anaerobic Lactic Energy
- Reduced Anaerobic Participation
- Reduced Blood Lactate
- Reduced Blood Lactate Accumulation
- Reduced Blood Lactate Level
- Reduced Carbohydrate Oxidation
- Reduced Enzyme Activity
- Reduced Lactate Level
- Reduced Low-Frequency Fatigue
- Regulated Carbohydrate Metabolism Enzyme Level